Ketamine for Migraines

 

Ketamine for Migraines Summary

Ketamine has been recognized as a rapid-acting intervention for treating Migraines whenever conventional therapies fail. Ketamine lowers sensitization in the pain pathways, offering much wanted relief.

Note: Ketamine has not yet officially been approved for treating migraines by the FDA, so its use is considered "off-label" and should only be done under supervision of a physician.

1) Mechanism of Action

Ketamine has been investigated as a treatment for refractory migraines and chronic migraine pain, especially when conventional therapies fail.

  • NMDA receptor antagonism causes reduced glutamate-mediated excitatory signaling
  • Reduction of central sensitization in pain pathways
  • Modulation of trigeminal nociceptive signaling
  • Reduction of wind-up phenomena in chronic pain circuits

These effects help interrupt persistent pain signaling in chronic migraine.

2) Clinical Indications

  • Refractory migraine
  • Chronic migraine
  • Status migrainosus (prolonged migraine attacks lasting more than 72 hours)
  • Failure of standard migraine treatments

3) Clinical Effects

Ketamine may provide rapid analgesic effects in some migraine patients, but results are variable.

  • Reduction in migraine pain intensity
  • Decreased central sensitization
  • Improved tolerance to sensory stimuli such as photophobia and phonophobia

4) Methods of Administration

Ketamine for migraine is typically administered in hospitals or specialized ketamine clinics.

  • Intravenous infusion (IVs)
  • Intranasal ketamine
  • Oral or sublingual ketamine in some experimental protocols

Continuous IV infusions over several hours to days may be used for severe refractory migraines.

5) Potential Advantages

  • Helps patients with refractory migraine
  • Can interrupt central sensitization
  • Reduces opioid requirements in severe headache disorders

6) Limitations and Risks

  • Inconsistent clinical response
  • Short duration of benefit
  • Potential for misuse or dependence

7) Adverse Effects

Common acute adverse effects include:

  • Dissociation
  • Dizziness
  • Sedation
  • Nausea
  • Perceptual disturbances
  • Transient increases in blood pressure

These effects usually resolve within a few hours after treatment.

8) Current Clinical Role

Ketamine can be used when patients have:

  • Severe refractory migraine
  • Status migrainosus
  • Failure of multiple standard migraine therapies